Clinical trial
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable…
NCT00489164 · Cordis US Corp., Industry · Terminated
Key facts
| NCT number | NCT00489164 |
|---|---|
| Title | Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions |
| Official title | A Randomized Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE) |
| Acronym | DECODE |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Diseases |
| Intervention type | Device |
| Interventions | Sirolimus-Eluting BX Velocity Balloon-Expandable Stent |
| Enrollment | 83 |
| Start date | Aug 1, 2002 |
| Completion | May 1, 2004 |
| First posted | Jun 21, 2007 |
| Last update posted | Nov 11, 2008 |
| Countries | China, India, Malaysia, Singapore, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: